These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20132884)

  • 1. A novel mifepristone-loaded implant for long-term treatment of endometriosis: in vitro and in vivo studies.
    Mei L; Bao J; Tang L; Zhang C; Wang H; Sun L; Ma G; Huang L; Yang J; Zhang L; Liu K; Song C; Sun H
    Eur J Pharm Sci; 2010 Mar; 39(5):421-7. PubMed ID: 20132884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A biodegradable levonorgestrel-releasing implant made of PCL/F68 compound as tested in rats and dogs.
    Ma G; Song C; Sun H; Yang J; Leng X
    Contraception; 2006 Aug; 74(2):141-7. PubMed ID: 16860052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo release of albumin using a biodegradable MPEG-PCL diblock copolymer as an in situ gel-forming carrier.
    Hyun H; Kim YH; Song IB; Lee JW; Kim MS; Khang G; Park K; Lee HB
    Biomacromolecules; 2007 Apr; 8(4):1093-100. PubMed ID: 17326678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective antitumor activity of paclitaxel-loaded poly (epsilon-caprolactone)/pluronic F68 nanoparticles after intratumoral delivery into the murine breast cancer model.
    Ma G; Yang J; Zhang L; Song C
    Anticancer Drugs; 2010 Mar; 21(3):261-9. PubMed ID: 20016371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of implant diameter, drug loading and end-capping on praziquantel release from PCL implants.
    Li C; Cheng L; Zhang Y; Guo S; Wu W
    Int J Pharm; 2010 Feb; 386(1-2):23-9. PubMed ID: 19895876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing formulation factors in preparing chitosan microparticles by spray-drying method.
    Huang YC; Chiang CH; Yeh MK
    J Microencapsul; 2003; 20(2):247-60. PubMed ID: 12554378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterization of novel poly(sebacic anhydride-co-Pluronic F68/F127) biopolymeric microspheres for the controlled release of nifedipine.
    Shelke NB; Aminabhavi TM
    Int J Pharm; 2007 Dec; 345(1-2):51-8. PubMed ID: 17616283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging drugs for endometriosis.
    Fedele L; Berlanda N
    Expert Opin Emerg Drugs; 2004 May; 9(1):167-77. PubMed ID: 15155142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mifepristone following conservative surgery in the treatment of endometriosis].
    Jiang J; Lu J; Wu R
    Zhonghua Fu Chan Ke Za Zhi; 2001 Dec; 36(12):717-20. PubMed ID: 16136889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved bioavailability of orally administered mifepristone from PLGA nanoparticles.
    He W; Horn SW; Hussain MD
    Int J Pharm; 2007 Apr; 334(1-2):173-8. PubMed ID: 17101249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on hydrophilic 5-fluorouracil release from hydrophobic poly(ε-caprolactone) cylindrical implants.
    Hou J; Li C; Cheng L; Guo S; Zhang Y; Tang T
    Drug Dev Ind Pharm; 2011 Sep; 37(9):1068-75. PubMed ID: 21449700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental studies and preliminary clinical trial of vinorelbine-loaded polymeric bioresorbable implants for the local treatment of solid tumors.
    Fournier C; Hecquet B; Bouffard P; Vert M; Caty A; Vilain MO; Vanseymortier L; Merle S; Krikorian A; Lefebvre JL
    Cancer Res; 1991 Oct; 51(19):5384-91. PubMed ID: 1913658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary report on the treatment of endometriosis with low-dose mifepristone (RU 486).
    Kettel LM; Murphy AA; Morales AJ; Yen SS
    Am J Obstet Gynecol; 1998 Jun; 178(6):1151-6. PubMed ID: 9662295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RU486: pharmacology and potential use in the treatment of endometriosis and leiomyomata uteri.
    Murphy AA; Castellano PZ
    Curr Opin Obstet Gynecol; 1994 Jun; 6(3):269-78. PubMed ID: 8038415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Docetaxel-Loaded Poly (ε-Caprolactone)/Pluronic F68 Nanoparticle Overcoming Multidrug Resistance for Breast Cancer Treatment.
    Mei L; Zhang Y; Zheng Y; Tian G; Song C; Yang D; Chen H; Sun H; Tian Y; Liu K; Li Z; Huang L
    Nanoscale Res Lett; 2009 Sep; 4(12):1530-9. PubMed ID: 20652101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mifepristone. Auxiliary therapeutic use in cancer and related disorders.
    Koide SS
    J Reprod Med; 1998 Jul; 43(7):551-60. PubMed ID: 9693404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of endometrial explants in a rat model of endometriosis treated with melatonin.
    Güney M; Oral B; Karahan N; Mungan T
    Fertil Steril; 2008 Apr; 89(4):934-42. PubMed ID: 17582405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pentoxifylline on vascular endothelial growth factor C and flk-1 expression on endometrial implants in the rat endometriosis model.
    Vlahos NF; Gregoriou O; Deliveliotou A; Perrea D; Vlachos A; Zhao Y; Lai J; Creatsas G
    Fertil Steril; 2010 Mar; 93(4):1316-23. PubMed ID: 19147132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of postsurgical tissue adhesion by anti-inflammatory drug-loaded pluronic mixtures with sol-gel transition behavior.
    Oh SH; Kim JK; Song KS; Noh SM; Ghil SH; Yuk SH; Lee JH
    J Biomed Mater Res A; 2005 Mar; 72(3):306-16. PubMed ID: 15654699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo evaluation of praziquantel loaded implants based on PEG/PCL blends.
    Cheng L; Lei L; Guo S
    Int J Pharm; 2010 Mar; 387(1-2):129-38. PubMed ID: 20005928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.